GUANGZHOU, China, April 30, 2026 /PRNewswire/ — Ma Jun, Vice President and Chief Science Innovation Officer of Infinitus (China) Company Ltd., was invited to attend the Functional Food Conference 2026 (FFC 2026), held recently in Hangzhou, Zhejiang Province, where he delivered a keynote presentation. In his remarks, Ma outlined the company’s research foundation and ongoing innovation in the functional food sector, highlighting findings from a randomized, double-blind, placebo-controlled human clinical study of its flagship product, Zengjian Oral Liquid, which demonstrated its efficacy in enhancing human immune function.

Themed “Functional Foods and Human Health,” this year’s conference was jointly organized by the FFC Organizing Committee and the National Engineering Research Center of Functional Food at Jiangnan University, among others. The event brought together more than 3,000 industry specialists, business representatives, and researchers from China and abroad to explore key topics including scientific innovation, product development, and industry trends in functional foods. Widely recognized as a leading professional exchange platform in China’s functional food sector, the conference serves as a key forum for industry exchange and development.

In his presentation, Ma provided a comprehensive overview of Infinitus’s user-centric research framework and outlined the company’s scientific approach and practical pathway for validating product efficacy. He noted that Infinitus consistently places consumers at the center of its efficacy research, drawing on advancements in herbal science to establish a robust system spanning material foundations, precise evaluation, and gold-standard validation. Building on its established work in cellular studies, model organisms, and animal research, the company continues to expand human evidence-based research, relying on rigorous scientific data to validate product performance and support more consistent industry practices.

At the conference, Infinitus also presented clinical trial findings on Zengjian Oral Liquid, marking a significant milestone in its evidence-based research efforts. The study employed a multi-center, randomized, double-blind, parallel-controlled design—widely regarded in evidence-based medicine as the gold standard—aimed at rigorously assessing the product’s ability to support human immune function in real-world settings.

According to the study findings[1], after 45 days of taking Zengjian Oral Liquid, participants’ Immune Vitality Index (SIV) increased significantly from Level 3 to Level 4, with more pronounced improvements observed among women and individuals aged 55 and above. After 90 days, subjects showed a notable rise in immune reserve cells (naive CD8+ T cells), along with substantial increases in immunoglobulin G (IgG) and IgM levels. These results demonstrate the product’s ability to strengthen immune reserves and enhance the body’s defense capacity, providing scientific support for its role in immune regulation.

As a company with a long-standing focus on the herbal health sector, Infinitus remains committed to applying principles from established wellness practices alongside modern scientific methods to explore the health benefits of herbal ingredients. The company has established an integrated innovation system spanning research, technology, and product development across the full value chain. At the conference, Infinitus presented its latest research and outlined its approach to product development, contributing to ongoing discussions within the functional food sector.

Looking ahead, Infinitus will continue to invest in herbal science, with a strong focus on evolving consumer health needs. The company aims to develop more high-quality, reliable herbal health products while strengthening evidence-based research to align with evolving industry expectations. Through these efforts, Infinitus seeks to deliver more targeted health solutions and support broader public health outcomes.

Reference: [1] Data source: “A Randomized, Double-Blind, Parallel-Controlled, Multi-Center Human Clinical Study on the Efficacy and Safety of Zengjian Oral Liquid in Supporting Immune Function”

https://www.infinitus.com.cn/c/2026-03-10/449382.shtml

LOS ANGELES, April 30, 2026 /PRNewswire/ — PartyWoo, a leading brand in coordinated party decoration solutions, today announced the launch of its officially licensed Baby Shark™ All-in-One Balloon Collection, bringing one of the world’s most recognizable children’s IPs into a cohesive, balloon-focused decoration format tailored for the U.S. celebration market.

This launch marks a strategic expansion of PartyWoo’s licensed portfolio, translating the globally beloved Baby Shark brand from The Pinkfong Company into a streamlined, design-forward decoration system optimized for modern at-home birthday celebrations and family gatherings.

The collection features a curated assortment of Baby Shark foil balloons alongside coordinating latex balloons, engineered with precise 1:1 design proportions to ensure visual accuracy and consistent brand representation. Offered in two ocean-inspired colorways, the collection enables families to create a cohesive, immersive party environment while maintaining a unified Baby Shark aesthetic throughout the space.

Designed as a true all-in-one decoration solution, the collection allows consumers to build a complete themed backdrop through a single, coordinated purchase. This structured format simplifies the planning process, reduces decision fatigue, and ensures visual consistency—addressing a key need in today’s convenience-driven celebration landscape.

Developed specifically with U.S. birthday formats in mind, the collection aligns with photo-centric party setups and social-sharing moments that define contemporary family celebrations.

The Baby Shark™ All-in-One Balloon Collection is now available through PartyWoo on Amazon, Target.com, and TikTok Shop, offering broad accessibility across leading e-commerce and social commerce platforms.

About PartyWoo

PartyWoo specializes in developing coordinated party decoration collections designed for modern family celebrations. Through officially licensed collaborations and design-driven product systems, the brand delivers visually cohesive, easy-to-execute solutions that bridge creativity and convenience for real-life events.

About The Pinkfong Company

The Pinkfong Company is a global entertainment company that delivers content and entertaining experiences around the world. Driven by award-winning brands and IPs, the company has created and distributed a range of content across genres and formats including original animated series, world live tours, interactive games, and more. Believing in the power of entertaining and engaging content, The Pinkfong Company is committed to connecting people around the world and bringing joy and inspiration to worldwide audiences of all ages. For more information, please visit the website or follow the company on LinkedIn.

Backed by Blockchain.com’s multi-billion dollar institutional BTC holdings, Blockchain Wealth provides high-net-worth clients with the liquidity and security to shift from passive exposure to active, onchain capital deployment.

By leveraging its global market experts, Blockchain Wealth is setting a new benchmark for access in crypto that reflects the standards of traditional private banking with the efficiency of blockchain-based infrastructure

LONDON, April 30, 2026 /PRNewswire/ — Blockchain.com, a global leader in cryptocurrency services for retail and institutional users, today announced the official launch of Blockchain Wealth, a premier full-service suite now available to a select global user base. Leveraging Blockchain.com’s expertise in global markets, Blockchain Wealth provides individuals with sophisticated, institutional-grade financial services. After years at the center of the crypto market and working with high-net-worth individuals, the company is moving Blockchain Wealth out of stealth mode to deliver unparalleled scale and trust to global investors.

Blockchain Wealth offers a world-class personalized experience that scales with the specific needs of the most active participants in the market. Participants in the program will also benefit from some of the highest and most competitive yield rates available in the industry. This comes at a time when institutional demand is accelerating, driven by hedge funds, corporations, and market makers seeking yield, liquidity, and value returning to onchain operations beyond BTC and ETH.

“Institutional investors on our platform have held billions of dollars in BTC for years, reflecting sustained conviction through multiple market cycles and reinforcing crypto’s role as a long term allocation, not a short term trade,” said Nic Cary, Co-Founder and Vice Chairman at Blockchain.com. “We’re now launching a bespoke program built for a new class of high-net worth participants who are moving beyond passive exposure and actively deploying capital onchain, bringing the kind of white-glove service private banks have offered their wealthiest clients for decades.”

The program provides an unrivaled level of personalization by leveraging Blockchain.com’s dedicated OTC desk to grant high-net clients direct, 24/7 individual support from the company’s seasoned market experts. Designed to be a comprehensive financial hub, the program will be the first to roll out the company’s most advanced products, including upcoming crypto-backed loans, which will offer clients flexible liquidity without requiring them to divest from their core positions. These capabilities position Blockchain Wealth as a capital-efficient solution for investors seeking to unlock liquidity while maintaining long-term exposure to digital assets.

Blockchain Wealth distinguishes itself through a robust global footprint that utilizes both onshore and offshore strategies to meet the diverse needs of investors from around the world. This expansive geographic coverage helps ensure that the program is accessible to eligible clients across the globe, including newly extended reach into Africa and Asia, making it a truly borderless wealth management solution. Operating across more than 70 jurisdictions, Blockchain.com combines global reach with a strong commitment to compliance, security, and transparency, reinforcing its position as a trusted partner for institutional capital.

As the digital asset landscape continues to mature, Blockchain.com is continuing to invest and build the infrastructure necessary for the future of programmable finance. Blockchain Wealth represents the next evolution of this mission, providing the tools, security, and individualized attention for the next generation of global wealth. As traditional finance and crypto continue to converge, Blockchain.com is uniquely positioned to serve as the bridge between these worlds, delivering the sophistication institutions expect with the innovation of onchain financial systems.

Eligible investors interested in the benefits of the Wealth program can find more information and contact the dedicated team through the official Blockchain.com platform here.

About Blockchain.com

Blockchain.com is connecting the world to the future of finance. The global leader in crypto services helping millions across the globe access cryptocurrency. Since its inception in 2011, Blockchain.com has earned the trust of more than 90 million wallets and over 40 million users, and has facilitated over $1.2 trillion in crypto transactions. Visit Blockchain.com for more information.

Media Contact: press@blockchain.com

Introducing Blockchain Wealth

Backed by Blockchain.com’s multi-billion dollar institutional BTC holdings, Blockchain Wealth provides high-net-worth clients with the liquidity and security to shift from passive exposure to active, onchain capital deployment.

By Nic Cary, Co-Founder and Vice Chairman

Today, we unveiled our bespoke program for high-net individuals, Blockchain Wealth, a premier full-service suite now available to a select global user base, providing high-net-worth individuals with sophisticated, institutional-grade financial services.

After years at the center of the crypto market and working with high-net-worth clients, we are moving this program out of stealth mode to deliver our scale and trust to the world’s most sophisticated investors. This program is specifically built for a new class of high-net worth participants who are moving beyond passive exposure and actively deploying capital onchain, bringing the kind of white-glove service private banks have offered their wealthiest clients for decades to crypto.

Blockchain Wealth is setting a new benchmark for access in crypto. We are combining the standards of traditional private banking with the efficiency of blockchain-based infrastructure to offer a world-class, personalized experience.

• Bespoke Personalization: Through our dedicated OTC desk, high-net clients receive direct, 24/7 support from seasoned market experts.
• Competitive Yield: Participants will benefit from some of the most competitive yield rates in the industry.
• Capital Efficiency: As a comprehensive financial hub, the program will roll out our most advanced products first, including upcoming crypto-backed loans. This allows clients to unlock flexible liquidity without divesting from their core positions.

Wealth is not bound by borders, and neither is our infrastructure. Operating across more than 70 jurisdictions, Blockchain Wealth utilizes both onshore and offshore strategies to meet the diverse needs of investors worldwide. We have recently extended our reach further into Africa and Asia, ensuring our commitment to compliance, security, and transparency remains a global priority.

As traditional finance and crypto continue to converge, Blockchain.com is uniquely positioned to serve as the bridge between these worlds, delivering the sophistication institutions expect with the innovation of onchain financial systems.

Eligible investors interested in the benefits of the Wealth program can find more information and contact the dedicated team or on our website: https://wealth.blockchain.com/

TOKYO, April 29, 2026 /PRNewswire/ — As the global biopharmaceutical industry undergoes rapid restructuring, two powerful forces—policy evolution and supply chain transformation—are reshaping Japan’s landscape. On one side, the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA) have built a solid regulatory framework to accelerate biosimilar development. On the other hand, geopolitical risks and economic policy shifts are driving a stronger focus on domestic production capacity and supply chain resilience. These trends are prominently on display at CPHI Japan 2026, where EirGenix (6589.TW, EirGenix) is actively expanding its presence to solidify its long-term position in the Japanese market.

Aligning with Policy and Market Shifts, EirGenix Deepens Its Japan Strategy

On the policy front, Japan laid the groundwork for biosimilars as early as 2009, with the PMDA establishing clear review mechanisms. Building on this foundation, the MHLW has continued to promote biosimilar adoption to ease the mounting pressure on the healthcare system caused by an aging population—improving drug accessibility and overall supply efficiency.

On the supply chain side, rising geopolitical tensions and vulnerabilities in critical drug sourcing have prompted a shift away from centralized manufacturing toward more regionalized, multi-point models. Japan is responding with targeted industrial policies and investment incentives to bolster domestic manufacturing and enhance supply chain resilience, ensuring stable access to essential medicines. In this environment, CDMO (contract development and manufacturing organization) services are evolving beyond traditional outsourcing. They now play a pivotal role in securing supply stability, speeding commercialization, and enabling scale-up—making localized collaboration combined with international expertise the mainstream approach in Japan’s biopharmaceutical sector.

For many international biotech players, Japan is no longer just an end-market destination; it has become a strategic hub for licensing deals, CDMO partnerships, and regional supply chain integration. “Japan ranks among the world’s top three pharmaceutical markets,” notes Dr. Portia Lin, Senior Vice President and Chief Business Officer of EirGenix. “It offers rich potential across product licensing, CDMO services, and regional supply chain development. While maintaining our existing client relationships, we are committed to deepening strategic collaborations and exploring opportunities in licensing, commercial partnerships, and even local manufacturing to strengthen our long-term competitiveness in Japan.”

Advancing on Both Commercial and Manufacturing Fronts—Supply Chain Stability Emerges as the Key Differentiator

In practice, EirGenix is pursuing a dual-track strategy that integrates CDMO services with its own biosimilar pipeline development. On one track, the company continues to expand its biologics CDMO offerings, supporting clients from early-stage development through commercial-scale production. On the other, it is advancing its biosimilar candidates and market entry plans—creating a mutually reinforcing growth engine between R&D and manufacturing.

In Japan specifically, EirGenix is forging partnerships with local players that bring deep regulatory expertise, commercialization capabilities, and established distribution networks. These collaborations will cover marketing authorization (MA) holder responsibilities, regulatory engagement, and market promotion to accelerate on-the-ground execution.

Over the medium to long term, the company will evaluate deeper manufacturing collaborations—such as technology transfers and backup capacity arrangements—based on partnership scale and market demand. This approach not only mitigates production risks and enhances supply resilience but also directly addresses Japanese expectations for “sustainable supply,” “controlled risk,” and “market-responsive” models. For potential partners, stability, long-term commitment, and regional backup capacity are increasingly becoming decisive factors in selecting collaborators.

Leveraging End-to-End Integration Expertise to Unlock Diverse Collaboration Opportunities in Japan

At this year’s CPHI Japan, EirGenix is positioning itself as a strategic partner with proven long-term potential and clear differentiation. The company offers comprehensive CMC (chemistry, manufacturing, and controls) capabilities spanning cell line development, process optimization, and GMP commercial manufacturing—all delivered through a seamless, one-stop platform. This full-spectrum experience helps clients reduce technical risks, accelerate development timelines, and improve clinical and commercial success rates.

Dr. Lin emphasizes that EirGenix brings valuable on-the-ground insight gained from years of collaboration with Japanese clients, including a strong grasp of local communication styles, decision-making rhythms, and market preferences. By combining licensing, CDMO services, and forward-looking regional strategies, the company is creating greater flexibility and new opportunities for Taiwan–Japan industry partnerships.

With policy support and ongoing supply chain reorganization, Japan’s biopharmaceutical market is moving decisively toward localized specialization and multifaceted collaboration. Participation in CPHI Japan not only connects companies with current market dynamics but also opens the door to a broader array of future partnership possibilities.

Contact information:
Phone: +886-2-2514-0360
Mail: press@geneonline.com

SAN FRANCISCO, April 30, 2026 /PRNewswire/ — At the Dreame NEXT Launch Event at the Palace of Fine Arts in San Francisco, Dreame Pool showcased its latest robotic pool cleaning solution — the Zircon 2 Pro, Zircon 2 Ultra, and the B2 Pro Automatic Charging Station, signaling a shift toward smarter yard maintenance.

Despite widespread adoption, most robotic pool cleaners still require manual handling, offer incomplete coverage, and rely on reactive navigation rather than environmental understanding. The Zircon 2 series represents a shift toward pool cleaning intelligence.

“We aim to address two of the biggest challenges in the pool cleaning industry,” said a spokesperson for Dreame Pool Robotic Cleaner. “The Zircon 2 Pro (paired with the B2 Pro Charging Station) ends the physical burden of manual handling, while the Zircon 2 Ultra utilizes underwater LiDAR and self-developed algorithms to enhance coverage accuracy.”

Zircon 2 Pro: Eliminating Manual Pool Cleaning Workflows

The Zircon 2 Pro is engineered to deliver a professional-grade, hands-free cleaning experience. When paired with its optional B2 Pro Automatic Charging Station, it enables a full-cycle, autonomous operation — cleaning, returning, docking, and recharging — activated by a single tap in the app. “It is built to eliminate manual handling that still exists in most pool cleaning routines today,” said the spokesperson.

• 8000 GPH Suction Power: Handles debris ranging from leaves to settled sand and twigs, with up to 4 hours of runtime per charge.
• PoolSense™ 2.0: Integrates 12 high-precision sensors to map pool environments and generate adaptive, multi-pattern path planning for thorough, non-random coverage.

Zircon 2 Ultra: Expanding Coverage and Precision

The Zircon 2 Ultra is positioned as a premium pool cleaning solution, designed for complex pool environments (up to 4,300 sq. ft.), allowing for more systematic and complete cleaning coverage. It supports precise 7-in-1 multi-zone cleaning, covering the surface, waterline, walls, floor, steps, corners, and the shallow zones within a single cycle. Additionally, Zircon 2 Ultra features Surface Docking, allowing users to command the robot to surface at a preferred location for easy retrieval.

Its performance is built on two core systems:

• Underwater LiDAR Navigation: Featuring PulseMap™ technology, the system integrates LDS LiDAR with a multi-sensor fusion system to generate an accurate 3D pool model, ensuring real-time environmental scanning and structured path planning in low-visibility conditions.
• Quad-Lift™ Four-Pump System: Surpassing industry-leading designs, its advanced architecture utilizes four dedicated pumps to deliver a massive 10,000 GPH of suction power*. By distributing suction power across seven cleaning zones, it reduces performance trade-offs.

A Shift Toward Autonomous Pool Care

With the Zircon 2 series, Dreame Pool focuses on reducing manual handling and improving cleaning completeness. By dissolving complex technology into the background, the company aims to transform your backyard into an effortless sanctuary.

About Dreame Technology

Founded in 2017, Dreame Technology is a global leader in high-end consumer electronics and intelligent manufacturing, committed to empowering lives through intelligent home solutions. For more information, visit https://yardcare.dreametech.com/ 

*Data based on internal testing by Dreame Lab